BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 38612708)

  • 1. Association between Parkinson's Disease and Cancer: New Findings and Possible Mediators.
    Surguchov A; Surguchev AA
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of Shared Genetic Risk Factors Between Parkinson's Disease and Cancers.
    Sugier PE; Lucotte EA; Domenighetti C; Law MH; Iles MM; Brown K; Amos C; McKay JD; Hung RJ; Karimi M; Bacq-Daian D; Boland-Augé A; Olaso R; Deleuze JF; Lesueur F; Ostroumova E; Kesminiene A; de Vathaire F; Guénel P; ; Sreelatha AAK; Schulte C; Grover S; May P; Bobbili DR; Radivojkov-Blagojevic M; Lichtner P; Singleton AB; Hernandez DG; Edsall C; Mellick GD; Zimprich A; Pirker W; Rogaeva E; Lang AE; Koks S; Taba P; Lesage S; Brice A; Corvol JC; Chartier-Harlin MC; Mutez E; Brockmann K; Deutschländer AB; Hadjigeorgiou GM; Dardiotis E; Stefanis L; Simitsi AM; Valente EM; Petrucci S; Straniero L; Zecchinelli A; Pezzoli G; Brighina L; Ferrarese C; Annesi G; Quattrone A; Gagliardi M; Matsuo H; Nakayama A; Hattori N; Nishioka K; Chung SJ; Kim YJ; Kolber P; van de Warrenburg BPC; Bloem BR; Aasly J; Toft M; Pihlstrøm L; Guedes LC; Ferreira JJ; Bardien S; Carr J; Tolosa E; Ezquerra M; Pastor P; Diez-Fairen M; Wirdefeldt K; Pedersen N; Ran C; Belin AC; Puschmann A; Rödström EY; Clarke CE; Morrison KE; Tan M; Krainc D; Burbulla LF; Farrer MJ; Kruger R; Gasser T; Sharma M; ; Truong T; Elbaz A
    Mov Disord; 2023 Apr; 38(4):604-615. PubMed ID: 36788297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson's Disease and Melanoma: Co-Occurrence and Mechanisms.
    Bose A; Petsko GA; Eliezer D
    J Parkinsons Dis; 2018; 8(3):385-398. PubMed ID: 29991141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double Trouble: Association of Malignant Melanoma with Sporadic and Genetic Forms of Parkinson's Disease and Asymptomatic Carriers of Related Genes: A Brief Report.
    Koros C; Simitsi AM; Bougea A; Papagiannakis N; Antonelou R; Pachi I; Angelopoulou E; Prentakis A; Zachou A; Chrysovitsanou C; Beratis I; Fragkiadaki S; Kontaxopoulou D; Eftymiopoulou E; Stanitsa E; Potagas C; Papageorgiou SG; Karavasilis E; Velonakis G; Prassopoulos V; Geronicola-Trapali X; Stefanis L
    Medicina (Kaunas); 2023 Jul; 59(8):. PubMed ID: 37629650
    [No Abstract]   [Full Text] [Related]  

  • 5. No Evidence for a Causal Relationship Between Cancers and Parkinson's Disease.
    Senkevich K; Bandres-Ciga S; Yu E; Liyanage UE; ; Noyce AJ; Gan-Or Z
    J Parkinsons Dis; 2021; 11(2):801-809. PubMed ID: 33646179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ubiquitin-proteasome system and Parkinson's diseases.
    Betarbet R; Sherer TB; Greenamyre JT
    Exp Neurol; 2005 Feb; 191 Suppl 1():S17-27. PubMed ID: 15629758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological proteins in Parkinson's disease: focus on the proteasome.
    Snyder H; Wolozin B
    J Mol Neurosci; 2004; 24(3):425-42. PubMed ID: 15655264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetics and environmental factors of Parkinson disease].
    Broussolle E; Thobois S
    Rev Neurol (Paris); 2002 Dec; 158 Spec no 1():S11-23. PubMed ID: 12690660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics of Parkinson's disease.
    Nussbaum RL; Polymeropoulos MH
    Hum Mol Genet; 1997; 6(10):1687-91. PubMed ID: 9300660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rare variants analysis of cutaneous malignant melanoma genes in Parkinson's disease.
    Lubbe SJ; Escott-Price V; Brice A; Gasser T; Pittman AM; Bras J; Hardy J; Heutink P; Wood NM; Singleton AB; Grosset DG; Carroll CB; Law MH; Demenais F; Iles MM; ; Bishop DT; Newton-Bishop J; Williams NM; Morris HR;
    Neurobiol Aging; 2016 Dec; 48():222.e1-222.e7. PubMed ID: 27640074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hair color, family history of melanoma, and the risk of Parkinson's disease: An analysis update.
    Flores-Torres MH; Bjornevik K; Zhang X; Gao X; Hung AY; Schwarzschild MA; Chen X; Ascherio A
    Parkinsonism Relat Disord; 2024 Feb; 119():105965. PubMed ID: 38142631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of familial Parkinson's disease and parkinsonism to the understanding of nigral degeneration in sporadic Parkinson's disease.
    Hattori N; Shimura H; Kubo S; Wang M; Shimizu N; Tanaka K; Mizuno Y
    J Neural Transm Suppl; 2000; (60):101-16. PubMed ID: 11205133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms of neurodegeneration in Parkinson's disease: clues from Mendelian syndromes.
    Lim KL; Lim TM
    IUBMB Life; 2003 Jun; 55(6):315-22. PubMed ID: 12938733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating melatonin levels: possible link between Parkinson's disease and cancer risk?
    Schernhammer E; Chen H; Ritz B
    Cancer Causes Control; 2006 May; 17(4):577-82. PubMed ID: 16596313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility loci for pigmentation and melanoma in relation to Parkinson's disease.
    Dong J; Gao J; Nalls M; Gao X; Huang X; Han J; Singleton AB; Chen H;
    Neurobiol Aging; 2014 Jun; 35(6):1512.e5-1512.e10. PubMed ID: 24439955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinson's disease: one biochemical pathway to fit all genes?
    Krüger R; Eberhardt O; Riess O; Schulz JB
    Trends Mol Med; 2002 May; 8(5):236-40. PubMed ID: 12067634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian melatonin rhythm and excessive daytime sleepiness in Parkinson disease.
    Videnovic A; Noble C; Reid KJ; Peng J; Turek FW; Marconi A; Rademaker AW; Simuni T; Zadikoff C; Zee PC
    JAMA Neurol; 2014 Apr; 71(4):463-9. PubMed ID: 24566763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanoma, Parkinson's disease and levodopa: causal or spurious link? A review of the literature.
    Zanetti R; Loria D; Rosso S
    Melanoma Res; 2006 Jun; 16(3):201-6. PubMed ID: 16718266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of Parkinson's disease genetics.
    Lorincz MT
    Semin Neurol; 2006 Nov; 26(5):492-8. PubMed ID: 17048150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.